Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1985 Jul;22(1):68-70.
doi: 10.1128/jcm.22.1.68-70.1985.

Detection of cytomegalovirus antibody with latex agglutination

Comparative Study

Detection of cytomegalovirus antibody with latex agglutination

S P Adler et al. J Clin Microbiol. 1985 Jul.

Abstract

Transfusion-acquired cytomegalovirus (CMV) infections should be prevented in seronegative immunocompromised patients by providing blood products from donors who are also seronegative. Latex agglutination was investigated as a simple and rapid method for detecting antibody against CMV. Latex beads were coated with CMV antigen, incubated for 8 min at room temperature with 25 microliter of sera, and examined for agglutination. The sensitivity and specificity of latex agglutination was compared with that of indirect hemagglutination (IHA, Cetus Corp., Emeryville, Calif.) and enzyme immunoassay (EIA) with sera from 604 random blood donors or patients. Of 327 serum samples shown to be seronegative by EIA and IHA, 327 had a latex agglutination titer of less than 1:4 (specificity, 100%). Of 236 serum samples with detectable antibody by EIA and IHA, 228 had a latex agglutination titer of 1:4 or greater (sensitivity, 97%). Plasma collected with EDTA, heparin, or citrate was satisfactory for latex agglutination. Latex agglutination results correlated quantitatively with those of EIA, and the test also detected fourfold or greater rises in antibody with paired sera from six patients with posttransfusion CMV infections. Latex agglutination is a sensitive and specific assay that is rapid and simple to perform and should be effective in selecting seronegative blood donors to prevent posttransfusion CMV infections in seronegative recipients.

PubMed Disclaimer

References

    1. J Clin Microbiol. 1979 Jul;10(1):64-8 - PubMed
    1. J Pediatr. 1981 Feb;98(2):281-7 - PubMed
    1. Transfusion. 1984 Jul-Aug;24(4):333-5 - PubMed
    1. J Clin Microbiol. 1983 Dec;18(6):1296-300 - PubMed
    1. Rev Infect Dis. 1983 Nov-Dec;5(6):977-93 - PubMed

Publication types

Substances

LinkOut - more resources